Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy

被引：0
作者：
Monica Verdoia
Patrizia Pergolini
Roberta Rolla
Matteo Nardin
Lucia Barbieri
Veronica Daffara
Paolo Marino
Giorgio Bellomo
Harry Suryapranata
Giuseppe De Luca
机构：
[1] Eastern Piedmont University,Department of Cardiology, Ospedale “Maggiore della Carità”
[2] Eastern Piedmont University,Clinical Chemistry, Ospedale “Maggiore della Carità”
[3] UMC St Radboud,Cardiology
来源：
Cardiovascular Drugs and Therapy | 2016年 / 30卷
关键词：
Clopidogrel; Coronary artery disease; Dual antiplatelet therapy; Gender; Platelet aggregation; Ticagrelor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：143 / 150
页数：7
相关论文
共 50 条
[21]   Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor [J].
Verdoia, M. ;
Pergolini, P. ;
Rolla, R. ;
Nardin, M. ;
Schaffer, A. ;
Barbieri, L. ;
Marino, P. ;
Bellomo, G. ;
Suryapranata, H. ;
De Luca, G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (01) :57-64
[22]   Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy [J].
Gremmel, Thomas ;
Steiner, Sabine ;
Seidinger, Daniela ;
Koppensteiner, Renate ;
Panzer, Simon ;
Kopp, Christoph W. .
THROMBOSIS RESEARCH, 2009, 124 (05) :588-591
[23]   Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy [J].
Verdoia, Monica ;
Pergolini, Patrizia ;
Rolla, Roberta ;
Ceccon, Claudia ;
Caputo, Marina ;
Aimaretti, Gianluca ;
Suryapranata, Harry ;
De Luca, Giuseppe .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2021, 129 (01) :43-49
[24]   Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: comment [J].
Tang, N. ;
Yin, S. Y. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (07) :1484-1485
[25]   Role of the laboratory in monitoring patients receiving dual antiplatelet therapy [J].
Vidali, M. ;
Rolla, R. ;
Parrella, M. ;
Cassani, C. ;
Manzini, M. ;
Portalupi, M. R. ;
Serino, R. ;
Prando, M. D. ;
Bellomo, G. ;
Pergolini, P. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2012, 34 (05) :484-494
[26]   Comparison of Three Tests to Distinguish Platelet Reactivity in Patients with Renal Impairment during Dual Antiplatelet Therapy [J].
Guo, Long Zhe ;
Kim, Moo Hyun ;
Kim, Tae Hyung ;
Park, Jong Seong ;
Jin, Enze ;
Shim, Chang Heon ;
Choi, Sun Young ;
Serebruany, Victor L. .
NEPHRON, 2016, 132 (03) :191-197
[27]   Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy [J].
Verdoia, Monica ;
Nardin, Matteo ;
Sartori, Chiara ;
Pergolini, Patrizia ;
Rolla, Roberta ;
Barbieri, Lucia ;
Marino, Paolo ;
Bellomo, Giorgio ;
Suryapranata, Harry ;
De Luca, Giuseppe .
ATHEROSCLEROSIS, 2015, 243 (02) :389-394
[28]   Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report [J].
Chyrchel, Bernadeta ;
Toton-Zuranska, Justyna ;
Kruszelnicka, Olga ;
Chyrchel, Michal ;
Mielecki, Waldemar ;
Kolton-Wroz, Maria ;
Wolkow, Pawel ;
Surdacki, Andrzej .
PLATELETS, 2015, 26 (06) :593-597
[29]   Role of Gender in Dual Antiplatelet Therapy After Acute Coronary Syndrome [J].
Mallidi, Jaya ;
Lata, Kusum .
CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (09)
[30]   Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome [J].
Tatarunas, Vacis ;
Kupstyte-Kristapone, Nora ;
Zvikas, Vaidotas ;
Jakstas, Valdas ;
Zaliunas, Remigijus ;
Lesauskaite, Vaiva .
SCIENTIFIC REPORTS, 2020, 10 (01) :3175
12345